These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17199818)

  • 41. Community-based genetic education: sources of information in a Tay Sachs disease screening program.
    Clark M; Palmer R; Kontras S
    Ohio State Med J; 1982 Mar; 78(3):218-20. PubMed ID: 7078924
    [No Abstract]   [Full Text] [Related]  

  • 42. The rabbi's dilemma. [Interview by Alison George].
    Ekstein J
    New Sci; 2004 Feb 14-20; 181(2434):44-7. PubMed ID: 15085821
    [No Abstract]   [Full Text] [Related]  

  • 43. Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews.
    Fernandes MJ; Kaplan F; Clow CL; Hechtman P; Scriver CR
    Genet Epidemiol; 1992; 9(3):169-75. PubMed ID: 1387862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pedigree discriminant analysis of two French Canadian Tay-Sachs families.
    Keats BJ; Elston RC; Andermann E
    Genet Epidemiol; 1987; 4(2):77-85. PubMed ID: 2953646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening Jews and genes: a consideration of the ethics of genetic screening within the Jewish community: challenges and responses.
    Levin M
    Genet Test; 1999; 3(2):207-13. PubMed ID: 10464669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tay-Sachs disease: to screen or not to screen.
    Rosner F
    Tradition; 1976; 15(4):101-12. PubMed ID: 11660898
    [No Abstract]   [Full Text] [Related]  

  • 47. Screening for Tay-Sachs disease.
    Int J Gynaecol Obstet; 1996 Mar; 52(3):311-2. PubMed ID: 8775693
    [No Abstract]   [Full Text] [Related]  

  • 48. Role of the physician in screening for carriers of Tay-Sachs disease.
    Lowden JA
    Can Med Assoc J; 1978 Sep; 119(6):575-8. PubMed ID: 709448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cystic fibrosis carrier population screening: a review.
    Rowley PT; Loader S; Levenkron JC
    Genet Test; 1997; 1(1):53-9. PubMed ID: 10464626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eugenics--sacred and profane.
    Rosen C
    New Atlantis; 2003; (2):79-89. PubMed ID: 15584198
    [No Abstract]   [Full Text] [Related]  

  • 51. Stigmatization of carrier status: social implications of heterozygote genetic screening programs.
    Kenen RH; Schmidt RM
    Am J Public Health; 1978 Nov; 68(11):1116-20. PubMed ID: 152585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seven years experience with Tay-Sachs screening in Florida.
    Tocci PM
    J Fla Med Assoc; 1981 Jan; 68(1):24-9. PubMed ID: 7217914
    [No Abstract]   [Full Text] [Related]  

  • 53. Determinants of utilization of Tay-Sachs screening.
    Garber AP; Platt LD; Wang SJ; Jam K; Carlson DE; Rotter JI
    Obstet Gynecol; 1993 Sep; 82(3):460-3. PubMed ID: 8355954
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Benefits and burdens of genetic carrier identification.
    Williams JK; Schutte DL
    West J Nurs Res; 1997 Feb; 19(1):71-81. PubMed ID: 9030039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
    Vallance H; Morris TJ; Coulter-Mackie M; Lim-Steele J; Kaback M
    Mol Genet Metab; 2006 Feb; 87(2):122-7. PubMed ID: 16352452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heterozygosity for Tay-Sachs and Sandhoff diseases among Massachusetts residents with French Canadian background.
    Prence EM; Jerome CA; Triggs-Raine BL; Natowicz MR
    J Med Screen; 1997; 4(3):133-6. PubMed ID: 9368869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computer assisted small-scale Tay-Sachs carrier screening.
    Toney JH; Quirk JM
    J Appl Biochem; 1983; 5(1-2):25-30. PubMed ID: 6236193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ethical and policy issues raised by heterozygote carrier identification and predictive genetic testing of adolescents.
    Ross LF
    Adolesc Med State Art Rev; 2011 Aug; 22(2):251-64, ix. PubMed ID: 22106739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tay-Sachs disease.
    Gelbart M
    Nurs Times; 1998 Mar 18-24; 94(11):39. PubMed ID: 9697531
    [No Abstract]   [Full Text] [Related]  

  • 60. Ethical Challenges in School-Based Immunization Programs for Adolescents: A Qualitative Study.
    Braunack-Mayer A; Skinner SR; Collins J; Tooher R; Proeve C; O'Keefe M; Burgess T; Watson M; Marshall H
    Am J Public Health; 2015 Jul; 105(7):1399-403. PubMed ID: 25602867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.